Abstract

The current revisions of various guidelines and criterions have pointed out the way for the diagnosis and treatment of thyroid carcinoma, and also made us more thoughtful about this. The diagnosis and treatment of thyroid carcinoma has changed from the previous one-size-fits-all model to the risk classification, and the pathological types has changed from the microscopic evidence to the genetic evidence. On the premise of improving the quality of patient’s life, we can provide the most appropriate treatment for patients through fully understanding the natural history and biological characteristics of thyroid carcinoma, reducing overdiagnosis and overtreatment. Key words: Differentiated thyroid carcinoma; Active surveillance; TSH suppression therapy; Overdiagnosis; Overtreatment

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.